---
title: "Avacta Appoints Healthcare Executive Patrick Vink as Deputy Chairman of the Board of Directors"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292024519.md"
description: "On July 8, 2026, Avacta Therapeutics, a clinical stage biopharmaceutical company focusing on developing pre|CISION® - a tumor-activated oncology delivery platform, announced the appointment of Dr. Patrick Vink as Non-Executive Deputy Chairman and Senior Independent Director to its Board of Directors. Dr. Vink, a seasoned healthcare executive, will bring his expertise to the Company. AVCT (AIM) saw a positive response to this news, with a notable increase in its stock value following the announcement."
datetime: "2026-07-08T06:33:34.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292024519.md)
  - [en](https://longbridge.com/en/news/292024519.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292024519.md)
---

# Avacta Appoints Healthcare Executive Patrick Vink as Deputy Chairman of the Board of Directors

On July 8, 2026, Avacta Therapeutics, a clinical stage biopharmaceutical company focusing on developing pre|CISION® - a tumor-activated oncology delivery platform, announced the appointment of Dr. Patrick Vink as Non-Executive Deputy Chairman and Senior Independent Director to its Board of Directors. Dr. Vink, a seasoned healthcare executive, will bring his expertise to the Company. AVCT (AIM) saw a positive response to this news, with a notable increase in its stock value following the announcement.

## Related News & Research

- [10:19 ETAbelZeta Receives EMA PRIME Designation for C-CAR168 in Lupus Nephritis and Systemic Lupus Erythematosus](https://longbridge.com/en/news/293227917.md)
- [BUZZ-Scribe Therapeutics set for New York debut after upsized $128.7 million IPO](https://longbridge.com/en/news/293754651.md)
- [BUZZ-Scribe Therapeutics surges in New York debut after upsized $128.7 million IPO](https://longbridge.com/en/news/293787034.md)
- [14:17 ETLilac Biosciences and Soin Neuroscience Announce Publication of Clinical Review on RNA Biomarkers for Neuropathic Pain](https://longbridge.com/en/news/293653885.md)
- [Thoresen Thai Agencies acquires 63,025-DWT Ultramax bulker M.V. Thor Phra Samut](https://longbridge.com/en/news/293452527.md)